AmerisourceBergen Corp. First Quarter Earnings Sneak Peek

S&P 500 (NYSE:SPY) component AmerisourceBergen Corp. (NYSE:ABC) will unveil its latest earnings on Thursday, January 26, 2012. AmerisourceBergen is a pharmaceutical services company providing drug distribution and related healthcare services to pharmacy, physician, and manufacturer customers based in North America.

AmerisourceBergen Corp. Earnings Preview Cheat Sheet.

Wall St. Earnings Expectations: The average estimate of analysts is for net income of 62 cents per share, a rise of 8.8% from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved up from 61 cents. Between one and three months ago, the average estimate moved up. It has been unchanged at 62 cents during the last month. For the year, analysts are projecting profit of $2.82 per share, a rise of 10.6% from last year.

Past Earnings Performance: Last quarter, the company beat estimates by 4 cents, coming in at net income of 60 cents a share versus the estimate of profit of 56 cents a share. It marked the fourth straight quarter of beating estimates.

Investing Insights: Will the iPad 3 Be the Next Catalyst for Apple’s Stock?

Wall St. Revenue Expectations: Analysts are projecting a rise of 0.5% in revenue from the year-earlier quarter to $19.99 billion.

Analyst Ratings: Analysts are bullish on this stock with 12 analysts rating it as a buy, none rating it as a sell and two rating it as a hold.

A Look Back: In the fourth quarter of the last fiscal year, profit rose 4.3% to $147.3 million (54 cents a share) from $141.2 million (50 cents a share) the year earlier, exceeding analyst expectations. Revenue rose 3.5% to $20.41 billion from $19.72 billion.

Key Stats:

The company has seen net income rise in three straight quarters. Net income rose 13% in the third quarter of the last fiscal year and 18.4% in the second quarter of the last fiscal year.

Revenue has risen the past four quarters. Revenue rose 2.9% in the third quarter of the last fiscal year from the year earlier, climbed 2.4% in the second quarter of the last fiscal year from the year-ago quarter and 2.9% in the first quarter of the last fiscal year.

Competitors to Watch: McKesson Corporation (NYSE:MCK), Cardinal Health, Inc. (NYSE:CAH), Henry Schein, Inc. (NASDAQ:HSIC), Omnicare, Inc. (NYSE:OCR), BioScrip Inc. (NASDAQ:BIOS), Grupo Casa Saba, S.A. (NYSE:SAB), Owens & Minor, Inc. (NYSE:OMI), Patterson Companies, Inc. (NASDAQ:PDCO), PSS World Medical, Inc. (NASDAQ:PSSI), and MWI Veterinary Supply, Inc. (NASDAQ:MWIV).

Stock Price Performance: During November 21, 2011 to January 20, 2012, the stock price had risen $3.37 (9.2%) from $36.72 to $40.09. The stock price saw one of its best stretches over the last year between April 18, 2011 and April 27, 2011 when shares rose for seven-straight days, rising 6.4% (+$2.51) over that span. It saw one of its worst periods between November 15, 2011 and November 25, 2011 when shares fell for eight-straight days, falling 8.3% (-$3.24) over that span.

(Company fundamentals by Xignite Financials. Earnings estimates provided by Zacks)

Investing Insights: Here’s Why Chipotle’s Stock Keeps Winning.